Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Pharmaceutical Industry News ••• Topics • Countries • U.S. States

Beta Blockers News Monitoring

Get by Email • RSS

Published on 04:28 GMT

Why Hydration Matters More Than Ever: Health First Physician Explains Warning Signs of Heat Stroke

core body temp. at 104 degrees Fahrenheit or higher is a main sign of heatstroke As the temperature climbs, so do the risks. One of the most dangerous summer threats is heat stroke, a medical emergency that can escalate fast if ignored. Beat the Florida …

Source: SpaceCoastDaily.com - Florida - Pending
Published on Jun 12, 2025

Discontinuation of Beta-Blockers Risky in Post-MI Patients with Preserved LVEF and Hypertension: ABYSS trial

A new study published in the European Heart Journal showed that patients with myocardial infarction (MI) and preserved left ventricular ejection fraction (LVEF) who discontinue beta-blocker therapy experience notable increases in heart rate and blood …

Source: Medical Dialogues - Indeterminate
Published on 08:50 GMT

The 5 most common types of insomnia and the best ways to treat each – plus experts answer your burning sleep questions

WE all need good quality sleep, ideally seven to nine hours a night. Without it, we put ourselves at increased risk of cardiovascular disease, anxiety, obesity and diabetes - not to mention being short-tempered and bleary-eyed. 6 Millions of us are …

Source: The Sun - Right-wing
Published on Jun 11, 2025

The discovery that cancer hacks nerves could lead to fairer treatments

One of the biggest, yet often-overlooked, good news stories of the century so far is how many people now survive cancer. Recent data reveals that today, half of those diagnosed with cancer in the UK will survive for at least 10 years, compared with just a …

Source: New Scientist - Neutral
Published on Jun 11, 2025

NICE Recommends Earlier Treatments for Chronic Heart Failure

Thousands of patients in England with early-stage chronic heart failure could benefit from earlier access to effective drug therapies under new draft guidance from the National Institute for Health and Care Excellence (NICE). The guidance, which updates …

Source: Medscape - Neutral
Published on Jun 14, 2025

Relationship Between Glycosylated Hemoglobin Concentration and Prognosis of Acute ST-Segment Elevation Myocardial ...

Introduction Cardiovascular diseases (CVDs) are among the leading causes of morbidity and mortality worldwide and often present clinically as acute myocardial infarction (AMI) for the first time.1,2 ST-segment elevation myocardial infarction (STEMI) …

Source: Dove Medical Press - Neutral
Published on Jun 13, 2025

ESPN's Mike Greenberg opens up about horrifying heart condition and the procedure he says changed his life

By ALEX RASKIN Published: 13:52 EDT, 13 June 2025 | Updated: 15:22 EDT, 13 June 2025 It wasn't just an irregular heartbeat bothering ESPN's Mike Greenburg when the married father of two was diagnosed with an atrial fibrillation (AFib) in 2015. As …

Source: Daily Mail - Right-wing
Published on Jun 13, 2025

Fast Five Quiz: Obstructive HCM Management

Hypertrophic cardiomyopathy (HCM) is a genetic cardiac disorder characterized by left ventricular hypertrophy in the absence of alternative cardiac, systemic, or metabolic diseases capable of causing such hypertrophy. Once the diagnosis is made, management …

Source: Medscape - Neutral
Published on Jun 13, 2025

ESPN star Mike Greenberg reveals private health battle and says ‘I couldn’t live like that’

MIKE GREENBERG has revealed his private health battle. The ESPN star has admitted that he was diagnosed with Atrial Fibrillation - known as AFib. 3 Mike Greenberg is a regular host on ESPNCredit: ESPN 3 He has been diagnosed with AFibCredit: Getty 3 He …

Source: The U.S. Sun - Right-wing
Published on Jun 12, 2025

Summer Insomnia Troubles? Here Are 10 Ways To Sleep Better

Summer nights can leave you sleepless. There are many drug-free ways to improve the quality and ... More duration of your sleep.getty Some people have no trouble sleeping on winter nights. But when summer hits, sleep troubles start. This phenomenon is …

Source: Forbes - Neutral
Published on Jun 12, 2025

How stress shapes cancer's course

About two millennia ago, the Greek physicians Hippocrates and Galen suggested that melancholia—depression brought on by an excess of "black bile" in the body—contributed to cancer. Since then, scores of researchers have investigated the …

Source: 103.7 Chuck FM - Georgia - Pending
Published on Jun 10, 2025

Mayo Clinic Q & A: Why a fluttering heart could lead to stroke

DEAR MAYO CLINIC: I've been diagnosed with atrial fibrillation. I've read that it puts me at greater risk of stroke. Can you tell me more about this? ANSWER: You may not have known you had atrial fibrillation (AFib) until your condition was …

Source: GMToday - Wisconsin - Indeterminate
Published on Jun 12, 2025

75-year-old went for a walk in ‘feels like’ 50°C heat: Here’s why he had kidney injury

You would not imagine that dehydration can lead to complications. But take the case of this 75-year-old man, who keeps to his morning routine of a walk and buying the day’s essentials from the neighbourhood bazaar. He insisted on his outdoor routine …

Source: The Indian Express - Center-left
Published on Jun 11, 2025

'We fake that we feel fine': Living with migraines changed the trajectory of this NL woman's life

Breadcrumb Trail Links Atlantic Canada Cape Breton Newfoundland & Labrador Newfoundland and Labrador Lifestyle Health Nova Scotia Halifax Prince Edward Island PEI Lifestyle St. John's senior Liz Ohle was diagnosed with migraines at a time very …

Source: Cape Breton Post - Neutral
Published on Jun 10, 2025

Global Research Trends in Oxidative Stress and Myocardial Fibrosis: A Dual-Software Bibliometric Study

Introduction MF is a common pathological change in the development of various cardiovascular diseases, characterized by the pathological remodeling of the ECM.1 Persistent fibrosis can affect myocardial metabolism, reduce tissue compliance, lead to …

Source: Dove Medical Press - Neutral

16 days 17:14:46

Featured Releases

Got News to Share? · Submit · See All

Published on June 15, 2025 - 14:00 GMT

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, ...

NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST). Such investors are advised to contact Danielle Peyton at …

Distribution channels: Consumer Goods, Law ...
Published on June 15, 2025 - 14:33 GMT

WST 重要截止日期：全美審訊法律顧問 ROSEN 鼓勵損失 10 萬美元以上的 West Pharmaceutical Services, Inc. 投資者在對 WST 提出證券集體訴訟的重要截止日期前聘請律師

紐約, June 15, 2025 (GLOBE NEWSWIRE) -- 事因：全球投資者權益律師事務所 Rosen Law Firm 提醒在 2023 年 2 月 16 日至 2025 年 2 月 12 日（包括首尾兩日，下稱「集體訴訟期」）期間購買了 West Pharmaceutical Services, Inc. (NYSE: WST) 普通股之人士注意，重要的首席原告截止日期為 2025 年 7 月 7 日。影響：如果您在集體訴訟期間購買 West …

Distribution channels: Consumer Goods, Law ...

Published on June 15, 2025 - 14:00 GMT

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rocket Pharmaceuticals, Inc. - RCKT

NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Rocket Pharmaceuticals, Inc. (“Rocket” or the “Company”) (NASDAQ: RCKT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw …

Distribution channels: Consumer Goods, Law ...
Published on June 15, 2025 - 14:00 GMT

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in UroGen Pharma Ltd. of Class ...

NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against UroGen Pharma Ltd. (“UroGen” or the “Company”) (NASDAQ: URGN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw. …

Distribution channels: Consumer Goods, Law ...

Published on June 15, 2025 - 14:33 GMT

WST IMPORTANT DEADLINE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors with ...

NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025, both dates inclusive ( …

Distribution channels: Consumer Goods, Law ...
Published on June 15, 2025 - 15:22 GMT

Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal ...

EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study New late-breaking data at EAACI showed Dupixent …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 15, 2025 - 15:22 GMT

Communiqué : Dupixent a démontré sa supériorité par rapport au Xolair dans la rhinosinusite chronique avec polypes ...

EAACI : Le Dupixent a démontré sa supériorité par rapport au Xolair (omalizumab) dans la rhinosinusite chronique avec polypes nasaux chez des patients atteints d’asthme coexistant dans la toute première étude respiratoire de phase 4 en comparaison directe …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 15, 2025 - 11:45 GMT

Translational Data Illustrate a Mechanism of Greater Potency with Verekitug, a Novel Antibody Antagonist of the TSLP ...

– Pharmacology modeling data presented at the European Academy of Allergy & Clinical Immunology (EAACI) Congress describe mechanistic insights for greater potency with verekitug compared to tezepelumab – – Supports potentially differentiated profile of …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Got news to share? Submit it now.

Load more pharmaceuticals news or search news using your own keywords. There are 822,445,362 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country

Pharmaceutical Industry News by U.S. State

Pharmaceutical Industry News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 05/18/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on June 15, 2025 - 12:13 GMT

Mindworks NLP Offers a Smoking Cessation Group Hypnosis Live Event in Bellevue – June 21

Mindworks NLP announces a public group hypnosis seminar on June 21 to help participants quit smoking using powerful subconscious change techniques. BELLEVUE, WA, UNITED STATES, June 15, 2025 /⁨EINPresswire.com⁩/ -- In a time when public health and …

Distribution channels: Companies, Culture, Society & Lifestyle ...
Published on June 15, 2025 - 12:06 GMT

Redefining Fabry Disease Care: Gene Therapy and Long-Acting ERT Prepare to Disrupt Status Quo | Competitive Intellignece

Fabry disease treatment is advancing rapidly with gene therapies and next-gen ERTs promising durable efficacy, reduced burden, and broader mutation coverage. AUSTIN, TX, UNITED STATES, June 15, 2025 /⁨EINPresswire.com⁩/ -- Fabry Disease, a rare, X …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 15, 2025 - 12:06 GMT

Rewriting the Playbook in MPS I: CNS-Penetrant ERTs and Gene Therapies Usher in a New Treatment Era | CI Insights

Emerging CNS‑targeting ERTs and gene therapies for MPS I show promise for neurocognitive benefits, reduced treatment burden, and better outcomes. AUSTIN, TX, UNITED STATES, June 15, 2025 /⁨EINPresswire.com⁩/ -- Mucopolysaccharidosis type I (MPS I) …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 15, 2025 - 12:06 GMT

Hunter Syndrome Therapeutics Evolve: Novel CNS-Targeting Therapies Set to Challenge Elaprase’s Market Monopoly

New CNS-penetrant therapies and gene therapies are poised to transform the Hunter Syndrome landscape, ending Elaprase’s long-standing treatment dominance. AUSTIN, TX, UNITED STATES, June 15, 2025 /⁨EINPresswire.com⁩/ -- Hunter Syndrome ( …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 15, 2025 - 04:30 GMT

Thorncrest Dental Brings Advanced Laser Dentistry to Etobicoke with Picasso Soft Tissue Laser

ETOBICOKE, ONTARIO, CANADA, June 15, 2025 /⁨EINPresswire.com⁩/ -- Thorncrest Dental is proud to introduce the Picasso Soft Tissue Laser, a cutting-edge addition to its suite of dental technologies, now available to patients in the Etobicoke community. This …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 15, 2025 - 15:22 GMT

Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal ...

EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study New late-breaking data at EAACI showed Dupixent …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 15, 2025 - 15:22 GMT

Communiqué : Dupixent a démontré sa supériorité par rapport au Xolair dans la rhinosinusite chronique avec polypes ...

EAACI : Le Dupixent a démontré sa supériorité par rapport au Xolair (omalizumab) dans la rhinosinusite chronique avec polypes nasaux chez des patients atteints d’asthme coexistant dans la toute première étude respiratoire de phase 4 en comparaison directe …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 15, 2025 - 15:21 GMT

Dupixent® (dupilumab) Demonstrated Superiority Over Xolair® (Omalizumab) in Chronic Rhinosinusitis with Nasal Polyps (...

New late-breaking data at EAACI showed Dupixent outperformed Xolair across all primary and secondary efficacy endpoints of CRSwNP and in all asthma-related endpoints Dupixent also outperformed Xolair in improving such key signs and symptoms as nasal polyp …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 15, 2025 - 03:00 GMT

Tom Jackobs Offers Fractional Sales Management for Heart-Led Wellness Practices

New service helps mission-driven businesses improve sales performance without building a full in-house sales team. LOS ANGELES, CA, UNITED STATES, June 15, 2025 /⁨EINPresswire.com⁩/ -- Tom Jackobs, international sales strategist, is now offering …

Distribution channels: Book Publishing Industry, Business & Economy ...
Published on June 15, 2025 - 14:45 GMT

Intellia Therapeutics Announces Positive Three-Year Data from Phase 1 Trial of Lonvoguran Ziclumeran (lonvo-z) in ...

With up to three years of follow-up, a single dose of lonvo-z led to a 98% mean reduction in monthly HAE attack rate in all 10 patients All 10 patients were attack-free and treatment-free for a median of 23 months through the latest follow-up, …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on June 15, 2025 - 12:00 GMT

New national report reveals critical gaps in asthma and COPD care

A new NRAP report has highlighted persistent and widespread gaps in the care of people with asthma and chronic obstructive pulmonary disease (COPD) across England and Wales, calling on integrated care boards and local health boards to mandate all eligible …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on June 15, 2025 - 12:00 GMT

RCP statement on Air India crash

RCP president, Dr Mumtaz Patel, said: ‘We are devastated by the plane crash in India today and the many lives it has claimed. Our thoughts and prayers are with everyone affected by this tragic incident. ‘We are directly contacting all our RCP members in …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on June 15, 2025 - 12:00 GMT

Latest ‘Focus on physicians’ survey closes with over 2000 responses from doctors across the UK

The 2025 ‘Focus on physicians’ survey – a joint project between the Royal College of Physicians (RCP), the Royal College of Physicians and Surgeons of Glasgow (RCPSG) and the Royal College of Physicians of Edinburgh (RCPE) – has now closed. The ‘Focus on …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on June 15, 2025 - 11:45 GMT

Translational Data Illustrate a Mechanism of Greater Potency with Verekitug, a Novel Antibody Antagonist of the TSLP ...

– Pharmacology modeling data presented at the European Academy of Allergy & Clinical Immunology (EAACI) Congress describe mechanistic insights for greater potency with verekitug compared to tezepelumab – – Supports potentially differentiated profile of …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on June 15, 2025 - 11:11 GMT

D-Bal Max 2025: Exploring the Science and Safety behind a Popular And Legal Dianabol Steroid For Muscle Growth

Glasgow, June 15, 2025 (GLOBE NEWSWIRE) -- In the quest for enhanced athletic performance and muscle growth, many fitness enthusiasts and bodybuilders turn to supplements. D-Bal Max has emerged as a noteworthy option that claims to replicate the muscle- …

Distribution channels:
Published on June 14, 2025 - 16:42 GMT

Blue Sky Scrubs Celebrates World Wind Day: Championing Clean Energy for a Healthier Planet

Blue Sky Medical Scrubs and Scrub Caps Celebrates World Wind Day: Championing Clean Energy for a Healthier Planet AUSTIN, TX, UNITED STATES, June 14, 2025 /⁨EINPresswire.com⁩/ -- In celebration of World Wind Day, Blue Sky Scrubs proudly joins the …

Distribution channels: Culture, Society & Lifestyle, Environment ...
Published on June 14, 2025 - 16:38 GMT

Cherry Blossoms and The Other Side, A Poetic Journey Through Grief and Beyond

LAWRENCE, MA, UNITED STATES, June 14, 2025 /⁨EINPresswire.com⁩/ -- Acclaimed writer and visual dramatist Dennis Mullings presents a powerful double release with Cherry Blossoms and The Other Side, two moving and visually arresting plays that navigate the …

Distribution channels: Book Publishing Industry, Culture, Society & Lifestyle ...
Published on June 14, 2025 - 16:28 GMT

ICN elects new President, José Luis Cobos Serrano and a new Board of Directors

ICN announces Dr José Luis Cobos Serrano as its 30th President at its Congress in Helsinki HELSINKI, FINLAND, June 14, 2025 /⁨EINPresswire.com⁩/ -- At the closing ceremony of ICN Congress 2025, ICN announced that it has elected Dr José Luis Cobos …

Distribution channels: Healthcare & Pharmaceuticals Industry, Human Rights ...
Published on June 14, 2025 - 14:48 GMT

Celldex Presents Data Demonstrating Profound Long Term Improvement in Angioedema in Barzolvolimab Phase 2 Study in ...

77% of patients (150 mg Q4W) treated with barzolvolimab who had angioedema at baseline were angioedema free at Week 52 Data further support barzolvolimab clinical benefit to patients with CSU HAMPTON, N.J., June 14, 2025 (GLOBE NEWSWIRE) -- Celldex …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 14, 2025 - 14:42 GMT

ThinkCareBelieve: Week 21 of America's Progress under President Trump

Washington D.C., June 14, 2025 (GLOBE NEWSWIRE) -- You can find the article here: https://thinkcarebelieve.blog/2025/06/14/week-21-of-americas-progress-under-president-trump/ ThinkCareBelieve has published an article on the …

Distribution channels: Book Publishing Industry, Healthcare & Pharmaceuticals Industry ...